Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article reviews existing and emerging treatment methods for androgenetic alopecia non-surgically, suggesting some could potentially reverse disease progression, but notes each approach still faces certain limitations.

This study retrospectively analyzed 14 postmenopausal women with frontal fibrosing alopecia, noting that 57% experienced total eyebrow loss, and all received various steroid treatments, highlighting the importance of early diagnosis to potentially delay disease progression.

Using minoxidil can cause severe skin reactions in some people.

This article discusses FDA-approved treatments for androgenetic alopecia in men, highlighting that both minoxidil and finasteride are similarly effective long-term therapies for stopping its progression, but reports no clinical results.

This case report describes a 14-year-old girl with congenital hypotrichosis who experienced improved hair density and thickness after 3 months of treatment with oral minoxidil.

This review discusses the epidemiology and available treatments for male androgenetic alopecia, noting that while current therapies can slow progression, they provide only partial hair restoration, and further research is needed for new strategies.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

Minoxidil lowers blood pressure effectively but may cause unwanted hair growth and other side effects.

This study found that oral minoxidil showed limited cosmetic effectiveness in treating severe alopecia areata, with only 18% of patients experiencing a noticeable response.

This article reviews expert opinions on combining pharmacologic treatments like minoxidil with hair transplantation, reporting improved hair density and regrowth in patients with partially functioning follicles.

This discussion suggests that acquired progressive kinking of hair in androgen-dependent scalp areas may indicate the early stages of androgenetic alopecia with a poor prognosis, but it offers no new clinical findings.

In this case report, a 46-year-old woman with familial frontal fibrosis alopecia experienced initial stabilization of hair loss with dutasteride and minoxidil, but artificial hair transplantation led to implant folliculitis, requiring removal of the fibers.

In this case report, a 5-year-old girl experienced extensive hypertrichosis after using topical minoxidil lotion unsupervised, which regressed after discontinuation, highlighting the need for medical oversight.

This study supports the idea that angiolymphoid hyperplasia with eosinophilia is an inflammatory process linked to immunologic injuries rather than a proliferative condition.

This study found that combining oral chelated Zinc with 5% minoxidil solution improved hair density and hair shaft diameter in women with female pattern hair loss, without reported side effects.

This article reviews the mechanism, usage, and alternatives of the medication minoxidil in dermatology and reports no new clinical outcomes.

In this case study, a 74-year-old patient with frontal fibrosing alopecia displayed unique trichoscopic and histopathological features, and treatments like 5-alpha reductase inhibitors and oral minoxidil effectively halted disease progression, highlighting the importance of comprehensive facial analysis for prognosis.

In this case report, a 28-year-old female developed allergic contact dermatitis from prolonged use of 5% topical minoxidil, suggesting that minoxidil itself may often be responsible for such reactions rather than propylene glycol.

In this case report, a 31-year-old male using topical minoxidil for androgenic alopecia developed diplopia and increased intraocular pressure, which improved after stopping minoxidil and using prostaglandin analogues, although a carbonic anhydrase inhibitor caused IOP to rise again during follow-up.

Oral minoxidil may slow male pattern baldness and cause body hair growth, but hair loss can happen after stopping it.

This review investigates whether combining microneedling with minoxidil is more effective than using minoxidil alone for increasing hair density and diameter in patients with alopecia. Results are not reported.

This study found that a combination of systemic cyproterone acetate, ethinyl estradiol, and 5% topical minoxidil significantly improved hair growth and prevented further hair loss in women with female pattern hair loss over six months, with the treatment being well-tolerated.

This review explores the use of topical and transdermal delivery for drugs and cosmetics, highlighting the benefits of avoiding side effects and rapid metabolism, with a focus on nanoparticulate formulations and techniques for studying skin penetration.

This article highlights that fractionated laser therapy is gaining attention as a minimally invasive and effective treatment for androgenetic alopecia, offering a potential solution to traditional treatments' limitations.

This study observed that without any treatment, hair counts did not increase, suggesting that counting methods are unlikely to explain the 'placebo-effect' seen in previous minoxidil studies.

This article reviews recent advancements in understanding hair follicle biology, with a focus on the potential for gene therapy in treating alopecia, but it reports no new research findings.

This article reviews the causes and current treatment options for androgenetic alopecia, reporting no new clinical findings and highlighting the need for more therapeutic choices.

This review discusses pharmacological treatments for pattern hair loss, focusing on minoxidil and finasteride's safety and efficacy, and reports no new clinical results.

In this case report, a 49-year-old woman with multifocal alopecia areata experienced a notable reduction in hair loss and improvement in hair growth and scalp health following individualized homeopathic treatment at Dr Batra's® Homeopathy Clinic.

This case report identified a new isotype of male androgenetic alopecia (inverse-MAGA) in a man successfully treated with finasteride and minoxidil, suggesting the need for future studies to evaluate this variant widely.